Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144898
Status:
COMPLETED
Last Update Posted:
2019-05-28
First Post:
2005-09-02
Brief Title:
GF-GS 01 Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
A Randomized Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection GS in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer
The GF-GS 01 study sponsored by a National Hospital Research Program compares this new surgical method with a classical method in patients having a negative sentinel node
The duration of the follow-up is 5 years
The GF-GS 01 study sponsored by a National Hospital Research Program compares this new surgical method with a classical method in patients having a negative sentinel node
The duration of the follow-up is 5 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None